MEDICAMEN BIOTECH
Back to Income Statement
|
MEDICAMEN BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹179 Cr | ₹141 Cr | ₹115 Cr | ₹11,271,608 Cr | ₹126 Cr |
What is the latest Revenue of MEDICAMEN BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹179 Cr |
| Mar2024 | ₹141 Cr |
| Mar2023 | ₹115 Cr |
| Mar2022 | ₹11,271,608 Cr |
| Mar2021 | ₹126 Cr |
How is Revenue of MEDICAMEN BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹179 Cr | 27.29 | |
| Mar2024 | ₹141 Cr | 22.02 | |
| Mar2023 | ₹115 Cr | -100.00 | |
| Mar2022 | ₹11,271,608 Cr | 8,980,974.92 | |
| Mar2021 | ₹126 Cr | - | |
Compare Revenue of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹320.6 Cr | 1.3% | -5.4% | -38.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | 1.3% |
-5.4% |
-38.8% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses